Trials / Sponsors / Myeloid Therapeutics
Myeloid Therapeutics
Industry · 4 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Exp HER2-Expressing Solid Tumors | Phase 1 | 2025-11-25 |
| Recruiting | A Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC Hepatocellular Carcinoma | Phase 1 | 2024-07-01 |
| Recruiting | Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors Epithelial Tumors, Malignant | Phase 1 | 2023-08-02 |
| Suspended | A Study of MT-101 in Subjects With CD5+ Relapsed/Refractory TCL Lymphoma, T-Cell, Peripheral, Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides | Phase 1 / Phase 2 | 2021-12-15 |